Therapy With Atorvastatin Versus Rosuvastatin Reduces Urinary Podocytes, Podocyte-Associated Molecules, And Proximal Tubule Dysfunction Biomarkers In Patients With Type 2 Diabetes Mellitus: A Pilot Study.

2018-03-07Author:adminpraise:0

Leave Message

*
*
*
*
*
*
*
VerifyCode
Message submitted successfully !